DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20194288

Association between various antioxidants in normals and chronic obstructive pulmonary disease, their alteration and impact of smoking and disease on levels of antioxidants

Kapil Bhatia, Vivek N. Ambade, Alka Sontakke, Dashrath Basannar

Abstract


Background: There is total alteration of various antioxidants in response to the oxidative stress, which is one of the major patho-physiologic hallmarks in chronic obstructive pulmonary disease (COPD) development. This study aims to establish the correlation between different antioxidants in normals and COPD, study the alteration in the correlation due to COPD and smoking as well as the impact of COPD and smoking on antioxidants levels.

Methods: Study comprises of 96 normals as group I and 96 COPD patients as group II. The antioxidants albumin (Alb), bilirubin (Bil), uric acid (UA) ceruloplasmin (Cp), glutathione peroxidase (GSHPx), catalase (CAT) and superoxide dismutase 3 (SOD3) were estimated.

Results: Significant lower serum Alb, UA, SOD3 and increased serum Cp and GSHPx were found in Group II. Significant correlation was found between Alb and UA (r=0.24); Bil and UA (r=0.26); Alb and CAT (r=0.211) and SOD3 and CAT (r=0.318) in normals. However, these correlations were altered in COPD where Alb correlates with Bil (r=0.235); UA with CAT (r=0.203) and SOD3 with GSHPx (r=-0.27). The correlation between SOD3 and CAT remained unaltered. Similar correlation of UA with Alb and Bil was observed in nonsmoker normals and between SOD3 and CAT in smoker normals. In COPD, no correlation was seen in nonsmokers, while in smokers Alb correlates with Bil (r=0.316) and SOD3 with CAT (r=0.317).

Conclusions: These alterations may have clinical ramifications in further understanding the pathogenesis of COPD and developing therapeutic approaches.


Keywords


Antioxidants, Albumin, Chronic obstructive pulmonary disease, Ceruloplasmin, Catalase, Uric acid

Full Text:

PDF

References


Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (Updated 2014). Available at: http://www.goldcopd.org. Accessed 24 Oct 2014.

MacNee W. Treatment of stable COPD: antioxidants. Eur Resp Rev. 2005 Sep;14(94):12-22.

Rahman I. The role of oxidative stress in the pathogenesis of COPD. Treat Resp Med. 2005 Jun 1;4(3):175-200.

Rahman I, MacNee W. Role of transcription factors in inflammatory lung diseases. Thorax. 1998 Jul 1;53(7):601-12.

Soriani M, Pietraforte D, Minetti M. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophysi. 1994 Jul 1;312(1):180-8.

Hilliker AJ, Duyf B, Evans D, Phillips JP. Urate-null rosy mutants of Drosophila melanogaster are hypersensitive to oxygen stress. Proc Nat Acad Scie. 1992 May 15;89(10):4343-7.

Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Nat Acad Scie. 1981 Nov 1;78(11):6858-62.

Cutler RG. Antioxidants, Aging, and Longevity. In Pryor WA (Ed), Free Radicals in Biology. Acad Press Inc. (ISBN 0-12-566506-7). 1984;6:371-428.

Bélanger S, Lavoie JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Neonatol. 1997;71(4):233-8.

Galdston M, Levytska V, Schwartz MS, Magnusson B. Ceruloplasmin. Increased serum concentration and impaired antioxidant activity in cigarette smokers, and ability to prevent suppression of elastase inhibitory capacity of alpha 1-proteinase inhibitor. Am Rev Resp Dis. 1984 Feb;129(2):258-63.

Dormandy TL. Free radical oxidation and antioxidants. Lancet. 1978;1:647-50.

Osaki S, Johnson D, Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem 1966;241:2746-51.

Taylor JC, Madison R, Wong E, Mittman C. Do Ceruloplasmin and Elastase inhibition abnormalities influence the pathogenesis of chronic obstructive pulmonary disease. Chest. 1984;8(6):45S.

Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003;167:1600-19.

Beyer W, Imlay J, Fridovich I. Superoxide dismutases. Prog Nucleic Acid Res Mol Biol. 1991;40:221-53

Gao F, Koenitzer JR, Tobolewski JM, Jiang D, Liang J, Noble PW, et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 2008;283:6058-66.

Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med , 2003;35(3): 236-56

Auten RL, O’Reilly MA, Oury TD, Nozik-Grayck E, Whorton MH. Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2006;290:L32-L40

Oury TD, Day BJ, Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med. 1996;20:957-965.

Chelikani P, Fita I, Loewen PC. Diversity of structures and properties among catalases. Cell Mol Life Sci. 2004;61(2):192-208.

Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, et al. Characterization of mammalian selenoproteome. Science. 2003;300:1439-43.

Yan H, Harding JJ. Glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase. Biochem J. 1997;328:599-605.

Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1-40.

Jindal SK, Malik SK. Smoking index- a measure to quantify cumulative smoking exposure. Lung India 1988;4:195-6.

Jindal SK, Malik SK. Smoking index- a measure to quantify cumulative smoking exposure. Lung India. 1988:VI4:195-196.

Verrills NM, Irwin JA, He XY, Wood LG, Powell H, Simpson JL, et al. Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;15;183(12):1633-43.

Moison RMW, Haasnoot AA, Zoeren-Grobben DV, Berger HM. Plasma Proteins in Acute and Chronic Lung Disease of the Newborn - a descriptive study. Free Radic Biol Med. 1998;(25)3:321-28.

Lykkesfeldt J, Viscovich M, Henrik EP. Plasma malondialdehyde is induced by smoking: a study with balanced antioxidant profiles. Br J of Nutr. 2004;92:203-6.

Ramsay L, Mitchell T, Shelton J. Plasma uric acid and plasma albumin in healthy subjects. Ann of the Rheumatic Dis. 1977;36:374-7.

Bogdanska JJ, Korneti P, Todorova B. Erythrocyte superoxide dismutase, glutathione peroxidase, and catalase in healthy male subjects in Republic of Macedonia. Bratisl Lek Listy 2003;104(3):108-14.

Mak JCW. Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance. Int J Tuberc Lung Dis. 2008;12(4):368-374.